The Latest Analyst Ratings For OrthoPediatrics
Portfolio Pulse from Benzinga Insights
OrthoPediatrics (NASDAQ:KIDS) has received mixed analyst ratings over the past three months, with two bullish and two indifferent ratings. The average 12-month price target has decreased by 5.1% to $37.25. Analysts have maintained or lowered their ratings, reflecting evolving market conditions. The company has shown strong revenue growth but faces challenges with asset utilization.
September 13, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OrthoPediatrics has received mixed analyst ratings, with a decrease in the average price target by 5.1% to $37.25. Analysts have maintained or lowered their ratings, indicating cautious sentiment. The company shows strong revenue growth but faces challenges in asset utilization.
The mixed analyst ratings and decrease in average price target suggest a cautious outlook for OrthoPediatrics. While the company shows strong revenue growth, challenges in asset utilization and a decrease in price target indicate potential concerns. The maintained and lowered ratings reflect analysts' cautious sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100